A few days earlier, Stryker’s Vice President of Investor Relations Jason Beach said in an earnings call that the company’s robotic shoulder was expected to launch toward the end of 2024.
During Zimmer Biomet’s earnings call, Mr. Tornos was asked about the company’s robotic shoulder opportunity in light of Stryker’s timeline. While he didn’t provide a specific timeline, Mr. Tornos said a launch could be soon.
“I’ll tell you frankly, I’ll be very surprised if we’re not first to market, given where we are in the development cycle,” Mr. Tornos said, as transcribed by Seeking Alpha. “My expectation remains that we’re going to be ahead.”
Mr. Tornos also said Zimmer Biomet in 2022 exceeded 300 installations of the Rosa total joint replacement robot and “exceeded that expectation across all three regions.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
